Target validation of ACLY as a novel anti-cancer drug target for hepatocellular carcinoma
Target validation of ACLY as a novel anti-cancer drug target for hepatocellular carcinoma
ACLY作为肝细胞癌新型抗癌药物靶点的靶点验证
批准号：
406582
负责人：
Wu Jianhan
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-12-01 至 2019-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ATP citrate lyase (ACLY) performs an essential role in de novo lipogenesis by catalyzing the synthesis of cytosolic acetyl-CoA. De novo lipogenesis is upregulated in cancer in order to compensate for the metabolic demands of rapid cell proliferation. This
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the relationship between molecular biomarkers of aging and metabolic multimorbidity
-
批准号：457493
-
项目类别：Studentship Programs
-
资助金额：$10.93万
-
财政年份：2021
-
负责人：Wu Jianhan
-
依托单位：
海外基金
